Tranexamic Acid Reduces Occult Blood Loss, Blood Transfusion, and Improves Recovery of Knee Function after Total Knee Arthroplasty: A Comparative Study

 

 Buy Article Permissions and Reprints

Abstract

This study intends to explore the effects of tranexamic acid (TA) on occult blood loss, blood transfusion, and recovery of knee function in patients undergoing total knee arthroplasty (TKA). From October 2013 to April 2015, 224 patients undergoing TKA were enrolled in this study. These patients were randomly assigned into the control group (intravenous infusion of normal saline), 10 mg/kg TA group (intravenous infusion of 10 mg/kg TA) and 15 mg/kg TA group (intravenous infusion of 15 mg/kg TA). Compared with the control group, the 10 and 15 mg/kg TA groups were lower in postoperative blood loss, occult blood loss, blood transfusion rate, and volume. In comparison to the control group, hemoglobin levels were lower and the number of red blood cells was higher at 7 days after surgery in the 10 and 15 mg/kg TA groups. Higher fibrinogen levels and lower prothrombin time (PT), activated partial thromboplastin time, D-dimer levels, thrombin time, lower the visual analog scale/score, and circumference diameter of knee joint were observed in the 10 and 15 mg/kg TA groups compared with the control group at 7 and 14 days after surgery. At 1 and 3 months after surgery, the knee joint range of motion scores, Hospital for Special Surgery scores, and Knee Society Score were increased in 10 and 15 mg/kg TA groups in comparison to the control group. TA could reduce occult blood loss and blood transfusion rate and improve recovery of knee function in patients undergoing TKA.

• References

• 1 Nunley RM, Ellison BS, Ruh EL. , et al. Are patient-specific cutting blocks cost-effective for total knee arthroplasty?. Clin Orthop Relat Res 2012; 470 (03) 889-894
  CrossrefPubMedGoogle Scholar
• 2 Bozic KJ, Kurtz SM, Lau E. , et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res 2010; 468 (01) 45-51
  CrossrefPubMedGoogle Scholar
• 3 Tan J, Chen H, Liu Q, Chen C, Huang W. A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res 2013; 184 (02) 880-887
  CrossrefPubMedGoogle Scholar
• 4 Zhang FJ, Xiao Y, Liu YB, Tian X, Gao ZG. Clinical effects of applying a tourniquet in total knee arthroplasty on blood loss. Chin Med J (Engl) 2010; 123 (21) 3030-3033
  PubMedGoogle Scholar
• 5 Gao F, Guo W, Sun W. , et al. Correlation between the coverage percentage of prosthesis and postoperative hidden blood loss in primary total knee arthroplasty. Chin Med J (Engl) 2014; 127 (12) 2265-2269
  PubMedGoogle Scholar
• 6 Zhang H, Chen J, Chen F, Que W. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 2012; 20 (09) 1742-1752
  CrossrefPubMedGoogle Scholar
• 7 Panteli M, Papakostidis C, Dahabreh Z, Giannoudis PV. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee 2013; 20 (05) 300-309
  CrossrefPubMedGoogle Scholar
• 8 Lozano M, Basora M, Peidro L. , et al. Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang 2008; 95 (01) 39-44
  CrossrefPubMedGoogle Scholar
• 9 Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. Am J Perinatol 2011; 28 (03) 233-240
  Article in Thieme ConnectPubMedGoogle Scholar
• 10 Lecker I, Wang DS, Romaschin AD, Peterson M, Mazer CD, Orser BA. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest 2012; 122 (12) 4654-4666
  CrossrefPubMedGoogle Scholar
• 11 Shakur H, Roberts I, Bautista R. , et al; CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376 (9734): 23-32
  CrossrefPubMedGoogle Scholar
• 12 Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology 1983; 58 (03) 277-280
  CrossrefPubMedGoogle Scholar
• 13 Yaray O, Akesen B, Ocaklioğlu G, Aydinli U. Validation of the Turkish version of the visual analog scale spine score in patients with spinal fractures. Acta Orthop Traumatol Turc 2011; 45 (05) 353-358
  PubMedGoogle Scholar
• 14 Hirschmann MT, Testa E, Amsler F, Friederich NF. The unhappy total knee arthroplasty (TKA) patient: higher WOMAC and lower KSS in depressed patients prior and after TKA. Knee Surg Sports Traumatol Arthrosc 2013; 21 (10) 2405-2411
  CrossrefPubMedGoogle Scholar
• 15 Noble Jr JW, Moore CA, Liu N. The value of patient-matched instrumentation in total knee arthroplasty. J Arthroplasty 2012; 27 (01) 153-155
  CrossrefPubMedGoogle Scholar
• 16 Horstmann WG, Slappendel R, van Hellemondt GG, Wymenga AW, Jack N, Everts PA. Autologous platelet gel in total knee arthroplasty: a prospective randomized study. Knee Surg Sports Traumatol Arthrosc 2011; 19 (01) 115-121
  PubMedGoogle Scholar
• 17 Huang GP, Jia XF, Xiang Z. , et al. Tranexamic acid reduces hidden blood loss in patients undergoing total knee arthroplasty: a comparative study and meta-analysis. Med Sci Monit 2016; 22: 797-802
  CrossrefPubMedGoogle Scholar
• 18 Chen X, Zhu X, Yang S, Lin W, Wang L. Tranexamic acid treatment decreases hidden blood loss in total knee arthroplasty. Am J Ther 2016; 23 (06) e1397-e1405
  CrossrefPubMedGoogle Scholar
• 19 Rosencher N, Kerkkamp HE, Macheras G. , et al; OSTHEO Investigation. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43 (04) 459-469
  CrossrefPubMedGoogle Scholar
• 20 Rajesparan K, Biant LC, Ahmad M, Field RE. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br 2009; 91 (06) 776-783
  PubMedGoogle Scholar
• 21 Alcelik I, Pollock RD, Sukeik M, Bettany-Saltikov J, Armstrong PM, Fismer P. A comparison of outcomes with and without a tourniquet in total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Arthroplasty 2012; 27 (03) 331-340
  CrossrefPubMedGoogle Scholar
• 22 Ishida K, Tsumura N, Kitagawa A. , et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 2011; 35 (11) 1639-1645
  CrossrefPubMedGoogle Scholar
• 23 Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009; 123 (05) 687-696
  CrossrefPubMedGoogle Scholar
• 24 Cid J, Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 2005; 45 (08) 1302-1307
  CrossrefPubMedGoogle Scholar
• 25 Kelley TC, Tucker KK, Adams MJ, Dalury DF. Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty. Transfusion 2014; 54 (01) 26-30
  CrossrefPubMedGoogle Scholar
• 26 Cap AP, Baer DG, Orman JA, Aden J, Ryan K, Blackbourne LH. Tranexamic acid for trauma patients: a critical review of the literature. J Trauma 2011; 71 (1, Suppl): S9-S14
  CrossrefPubMedGoogle Scholar
• 27 Zhang W, Li N, Chen S, Tan Y, Al-Aidaros M, Chen L. The effects of a tourniquet used in total knee arthroplasty: a meta-analysis. J Orthop Surg 2014; 9 (01) 13
  CrossrefPubMedGoogle Scholar